Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
RSC Advances|April 15, 2022
Two-step formulation of magnetic nanoprobes for microRNA captureIveta Vilímová, Igor Chourpa, Stéphanie David, et al.
Pharmaceutical Research|November 24, 2004
Novel long-circulating lipid nanocapsulesDidier Hoarau, Pascal Delmas, Stéphanie David, et al.
Genetica|September 19, 2009
Nature as a source of inspiration for cationic lipid synthesisRomain Labas, Fanny Beilvert, Benoit Barteau, et al.
The Prostate|June 22, 2010
Effects of castration on insulin levels and glucose tolerance in the mouse differ from those in manTakamitsu Inoue, Mahvash Zakikhani, Stéphanie David, et al.
Human Gene Therapy|June 30, 2025
Autologous Production: The Future of Sustainable Antibody TreatmentsSteevens Bouaziz, Florence Rouleux-Bonnin, Stéphanie David, et al.
International Journal of Pharmaceutics|October 25, 2022
WITHDRAWN: In vitro synergistic activity of cisplatin and EGFR-targeted nanomedicine of anti-Bcl-xL siRNA in a non-small lung cancer cell line modelPhuoc Vinh Nguyen, Katel Hervé-Aubert, Laurie Lajoie, et al.
International Journal of Pharmaceutics: X|November 24, 2022
<i>In vitro</i> synergistic activity of cisplatin and EGFR-targeted nanomedicine of anti-Bcl-xL siRNA in a non-small lung cancer cell line modelPhuoc Vinh Nguyen, Katel Hervé-Aubert, Laurie Lajoie, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 6, 2026
Development of anti-EGFR targeted magnetic nanoparticles for doxorubicin delivery into triple negative breast cancer cellsChloé Lameli, Stéphanie David, Emilie Allard-Vannier, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 15, 2020
Targeted nanomedicine with anti-EGFR scFv for siRNA delivery into triple negative breast cancer cellsPhuoc Vinh Nguyen, Katel Hervé-Aubert, Stéphanie David, et al.
Pageof 2